Microsite Matches Oncology Sponsors with Canadian Investigators

February 20, 2014

Applied Clinical Trials

Scimega Research, an oncology-focused CRO, has launched its new Reverse Feasibility Resource Center

Scimega Research, (www.scimega.com) an oncology-focused CRO, has launched its new Reverse Feasibility Resource Center, that is aimed at matching U.S. oncology sponsors in need of Canadian investigators and their patients.

This microsite will be updated regularly to highlight Canada’s expertise in both early and late phase oncology trials. It currently features important information such as the number of oncology sites, key investigators, and the size of the catchment areas for each of the ten Canadian provinces. Sponsors can sign up to receive free quarterly updates on the types of trials Scimega’s Reverse Feasibility Champions are looking to participate in. This Oncology Trial Needs Report for Canada will highlight the number of sites actively looking for a trial, including lines of treatment, tumor types and targets.

Read the full release here.